Spelling suggestions: "subject:"L- asparaginase"" "subject:"L- asparaginases""
51 |
Role fúzního proteinu ETV6-RUNX1 v citlivosti leukemických buněk na L-asparaginázu / The role of ETV6-RUNX1 fusion protein in the sensitivity of leukemic cells to L-asparaginaseStaněk, Petr January 2018 (has links)
Translocation t(12;21) with the presence of the fusion gene ETV6-RUNX1 (TEL-AML1) is the most common chromosomal aberration found in acute lymphoblastic leukemia in childhood. The occurrence of the ETV6-RUNX1 is associated with excellent prognosis and high sensitivity to the treatment with the enzyme L-asparaginase (ASNase). Resistance to the drug aggravates the outlook of the patient and increases the risk of treatment failure, therefore, the CLIP working group has been for a long time involved in the identification of the mechanism of action of ASNase and the origin of the resistance to it. This thesis follows previous findings of the group and is devoted to the analysis of the importance of ETV6-RUNX1 and signalization and metabolic changes accompanying shifts in the L-asparaginase resistance. In the first part of the thesis, the knockout clones with stable increased resistance to ASNase have been established thanks to the CRISPR/Cas9 system, which created frameshift in the fusion gene. The accomplishment in this regard and removal of the fusion protein was confirmed on the level of DNA, mRNA a protein expression. The presence of other significant chromosomal aberrations affection the sensitivity to ASNase was ruled out by the means of SNP analysis. In the second part of the project, the signalization...
|
52 |
Role fúzního proteinu ETV6-RUNX1 v citlivosti leukemických buněk na L-asparaginázu / The role of ETV6-RUNX1 fusion protein in the sensitivity of leukemic cells to L-asparaginaseStaněk, Petr January 2018 (has links)
Translocation t(12;21) with the presence of the fusion gene ETV6-RUNX1 (TEL-AML1) is the most common chromosomal aberration found in acute lymphoblastic leukemia in childhood. The occurrence of the ETV6-RUNX1 is associated with excellent prognosis and high sensitivity to the treatment with the enzyme L-asparaginase (ASNase). Resistance to the drug aggravates the outlook of the patient and increases the risk of treatment failure, therefore, the CLIP working group has been for a long time involved in the identification of the mechanism of action of ASNase and the origin of the resistance to it. This thesis follows previous findings of the group and is devoted to the analysis of the importance of ETV6-RUNX1 and signalization and metabolic changes accompanying shifts in the L-asparaginase resistance. In the first part of the thesis, the knockout clones with stable increased resistance to ASNase have been established thanks to the CRISPR/Cas9 system, which created frameshift in the fusion gene. The accomplishment in this regard and removal of the fusion protein was confirmed on the level of DNA, mRNA a protein expression. The presence of other significant chromosomal aberrations affection the sensitivity to ASNase was ruled out by the means of SNP analysis. In the second part of the project, the signalization...
|
53 |
Caractérisation du microDNome et sa modulation par le traitement anti-cancerMehanna, Pamela 11 1900 (has links)
Récemment, une nouvelle classe d'ADN circulaire extrachromosomique (eccDNA) appelée microADN a été identifiée dans des tissus humains et murins. Ces microADNs ont une longueur de 100 à 400 pb, sont dérivés de régions génomiques non répétitives uniques et présentent un enrichissement au niveau des régions géniques et riches en GC. Bien qu'il ait été proposé qu'ils puissent provenir du métabolisme de l'ARN ou des défauts de réplication, leurs mécanismes de production et leur éventuelle fonctionnalité restent à déterminer. Grâce à l'analyse des microADNs extraits d'une série de 10 lignées cellulaires lymphoblastoïdes humaines (LCL), nous avons confirmé la distribution nonaléatoire des microADNs vers les régions actives du génome. Les microADNs identifiés présentaient
des loci d'origine redondants et une périodicité de taille de 190 pb pouvant correspondre à la fragmentation de l'ADN lors de l'apoptose caspase-dépendante. L'apoptose induite de ces LCLs par des drogues chimiothérapeutiques (méthotrexate ou L-asparaginase) a entrainé la modulation de la diversité et de la taille des microADNs, suggérant qu'une partie de ces entités pourrait être des produits résiduels de la mort cellulaire apoptotique. Ainsi, bien que compatible avec l'observation initiale suggérant que les microADNs proviennent d'un processus physiologique normal, ces résultats impliquent une source de production alternative ou complémentaire. / Recently, a new class of extrachromosomal circular DNA (eccDNA) called microDNA was identified in mouse and human tissues. These microDNAs are 100 to 400 bp long, derive from unique nonrepetitive genomic regions and show an enrichment in GC rich and genic sequences. While it has been proposed that they could arise from RNA metabolism or replication defects, their production mechanisms and eventual functionality remain unclear. Through the analysis of microDNAs extracted from a series of 10 human lymphoblastoid cell lines (LCLs), we confirmed the non-random distribution of microDNA towards active regions of the genome. Identified microDNAs showed redundant loci of origin and a size periodicity of 190 bp that matched caspase-dependant DNA fragmentation of apoptotic cells. Strikingly, the chemotherapeutic drug-induced apoptosis (using methotrexate or Lasparaginase) of these LCLs modulated both diversity and size of microDNAs further suggesting that a part of microDNAs could represent circularized by-products of the programmed cell death. Thus, while compatible with the original observation that microDNAs originated from a normal physiological process, these results imply an alternative or complementary source of production.
|
54 |
Assimila??o de nitrog?nio e crescimento apical em fungos filamentosos produtores de L-asparaginaseGon?alves, Aline Bacelar 30 September 2016 (has links)
Submitted by Jos? Henrique Henrique (jose.neves@ufvjm.edu.br) on 2017-09-12T18:28:33Z
No. of bitstreams: 2
license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
aline_bacelar_goncalves.pdf: 5988024 bytes, checksum: 24d09b3ca0a2e58cc7aee0ca7ca2528f (MD5) / Approved for entry into archive by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2017-09-18T12:57:54Z (GMT) No. of bitstreams: 2
license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
aline_bacelar_goncalves.pdf: 5988024 bytes, checksum: 24d09b3ca0a2e58cc7aee0ca7ca2528f (MD5) / Made available in DSpace on 2017-09-18T12:57:54Z (GMT). No. of bitstreams: 2
license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
aline_bacelar_goncalves.pdf: 5988024 bytes, checksum: 24d09b3ca0a2e58cc7aee0ca7ca2528f (MD5)
Previous issue date: 2017 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / O tratamento das leucemias ? desafiador por v?rios aspectos, entre os quais podem ser destacados os efeitos adversos e a obten??o de op??es terap?uticas de alta qualidade e de custos razo?veis. A utiliza??o da enzima L-asparaginase como agente terap?utico, limita a fonte ex?gena de asparagina, da qual as c?lulas malignas dependem para o metabolismo celular e para a sobreviv?ncia. Essa ? uma op??o que oferece menores riscos ao paciente e ?s c?lulas sadias, que s?o capazes de sintetizar este amino?cido. Neste cen?rio o objetivo deste trabalho foi selecionar, entre fungos filamentosos, linhagens produtoras da enzima L-asparaginase. O estudo tamb?m buscou avaliar o efeito da varia??o da fonte de carbono e da raz?o carbono-nitrog?nio no crescimento e na express?o da atividade enzim?tica, a fim de desenvolver meios de cultivo para o processo produtivo. Realizou-se tamb?m um estudo do crescimento apical das tr?s linhagens selecionadas, duas do g?nero Penicillium sp. e uma do g?nero Fusarium sp., em diversos meios de cultivo. O conhecimento gerado sobre as linhagens produtoras e os demais estudos realizados permitiram a obten??o de um meio de cultivo que possibilitou a produ??o enzim?tica em at? 11,45 U.min-1.mL-1 com a linhagem de Fusarium sp. / Disserta??o (Mestrado) ? Programa de P?s-gradua??o em Ci?ncias Farmac?uticas, Universidade Federal dos Vales do Jequitinhonha e Mucuri, 2016. / The treatment of leukemia is challenging in many ways, including the adverse effects and obtaining treatment options of high quality and reasonable cost. The use of L-asparaginase enzyme as a therapeutic agent limits the exogenous source of asparagine, which the malignant cells depend for cellular metabolism and survival. This option offers lower risk to patients and healthy cells, which are able to synthesize this amino acid. Therefore, the objective of this work was to select among filamentous fungi, producing strains of L-asparaginase enzyme. The study also aimed at evaluating the effect of varying the carbon source and carbon-nitrogen ratio in the growth and expression of the enzymatic activity to develop culture media for the production process. It was also carried out a study of the apical growth of the three strains selected, two of the genus Penicillium sp. and one Fusarium sp., cultivated in various culture media. The knowledge about the growth of the strains studied in different nutritional sources and other studies allowed obtaining a culture medium that enabled the enzyme production of 11.45 U.min-1.mL-1 by Fusarium sp.
|
55 |
Vliv přídavných látek na obsah akrylamidu v tepelně opracovaných potravinách / Effect of additives on acrylamide content in thermally treated foodsMarková, Lucie January 2009 (has links)
Acrylamide is an undesirable carcinogenic component of thermally processed foods being formed from reducing saccharides and asparagine. In this work, the effect of ammonium and sodium raising agents themselves or in their combination with L-asparaginase enzyme catalyzing the conversion of asparagine into aspartic acid resulting in the reduction of acrylamide in gingerbreads was studied. Also, the influence of selected inorganic salts on the content of acrylamide in a model matrix simulating a composition of cereal products was observed. Simultaneously, the impact of these salts on activity of L-asparaginase was examined to find optimal conditions for its application in cereal technology. Based on experiments it was found, that addition of L-asparaginase reduces acrylamide content by 40 % while inorganic salts addition decreases acrylamide content in the range of 30 - 99 % when the most effective compounds were NH4Cl and CaCl2.
|
56 |
Studium podmínek vzniku a eliminace akrylamidu vznikajícího při tepelném zpracování potravin. / Study of Formation and Elimination of Acrylamide in Food Matrix during Heat Treatment.Marková, Lucie January 2013 (has links)
Acrylamide (AA) is a probable human carcinogen and undesirable contaminant which is produced by the reaction of reducing sugars with asparagine in plant foods during their thermal treatment above 120 °C. AA is most often determined by GC-MS and LC-MS/MS in isolates from the matrix in a wide range of foods. According to our observations, AA intake from food is higher among young people (from 1.8 to 3.8 µg/kg bw/day), which is consistent with the estimations of JECFA FAO/WHO from the year 2006. Considering the health risk, it is recommended to reduce AA formation in food during its processing, in particular exploiting the available experience. The aim of this thesis was to extend the knowledge of the possibility of AA elimination in selected types of thermally processed foods. The study was focused on cereal foods that contribute significantly to AA exposure, especially bread and sweet biscuits. The whole AA content in the bread is in the crust, which represents 5-15% of the bread. Crust of home-made bread contains approximately 30-75 µg/kg, however the marketed bread contains 2 to 10 times more of AA. This is due to the composition of bread mix, preparation conditions and baking. For maintaining the quality of home-made bread during the dry mixture shelf-life, optimization of bread mixtures was designed by increasing of yeast content, which proved positive effect on the reduction of AA content at sufficiently high activity of the yeast. Monitoring of AA content in assortment of sweet bakery products showed higher levels of AA in diabetic biscuits containing fructose instead of sucrose. Three of them even exceeded the reference value (500 µg/kg) more than 1.5 times for commodity "cookies". Elimination of AA by applications of the enzyme asparaginase has been designed for minimal interference in technology of their production. The concentration of the enzyme and the appropriate method of its use in industrial environment have been tested previously in model systems. In optimized conditions of the enzyme application, AA content in diabetic biscuits was reduced by more than 40% without affecting the organoleptic properties of the final product. Effect of the antioxidants on AA formation was also part of the study. AA content in gingerbread was reduced efficiently by the use of fennel, anise, cloves, vanilla and white pepper (by about 9-21%). Conversely, coriander and cinnamon significantly increased its content (by 18-54%). Since correlations between the DPPH• radical quenching activity of the spice extracts and AA content was not observed, the final content of AA was probably influenced by the chemical composition of spices and reactivity of the individual components in the matrix. Investigated methods appear to be suitable ways of elimination AA in some foods; however their specific use must be optimized with regard to the composition of the food, processing and the technology used. Estimated impact of application of the above-mentioned methods to the overall elimination of AA exposure showed that its intake in high school students from the Czech and Slovak Republic can be reduced on average by 10%. This decrease is a success to reduce the possible risk of cancer disease by eating foods with a high AA content. It is also important piece of information for food producers for further development of relevant methods for AA elimination which would help to reduce the AA intake from foods even more.
|
57 |
Avaliação da atividade e resistência à clivagem proteolítica de L-asparaginases recombinantes obtidas por reação em cadeia da polimerase propensa a erro / Evaluation of the activity and resistance to proteolytic cleavage of recombinant L-asparaginases obtained by error-Prone polymerase chain reactionRodrigues, Mariane Augusta Domingues 30 March 2016 (has links)
A L-Asparaginase II de Escherichia coli (EcA II) é uma enzima amplamente utilizada no tratamento da Leucemia Linfoblástica Aguda (LLA), atuando na depleção do aminoácido L-asparagina, o qual é fundamental para a multiplicação das células cancerosas. Contudo, o tratamento com a EcA II está associado a altos índices de hipersensibilidade, devido à formação de anticorpos anti-L-asparaginase e à clivagem da enzima pelas proteases sanguíneas asparagina endopeptidase (AEP) e catepsina B (CTSB). Também ocorre neurotoxicidade associada ao efeito L-glutaminase da enzima. O principal objetivo do presente trabalho é a obtenção de mutantes da EcA II (gene ansB) com equivalente eficiência catalítica, maior resistência à clivagem proteolítica e menor atividade glutaminase. Para este propósito, através da reação em cadeia da polimerase propensa a erro (epPCR) do gene ansB, foi construída uma biblioteca de 1128 clones expressos no vetor pET15b em BL21(DE3). Nenhum mutante com atividade asparaginásica equivalente à EcA II selvagem apresentou atividade glutaminásica inferior à esta. Dentre os clones triados obtivemos um mutante (T161I) resistente à clivagem proteolítica pela CTSB e dois mutantes (Q190L e P40S/S206C) resistentes à clivagem proteolítica por ambas AEP e CTSB. Estes três mutantes apresentaram atividade asparaginásica e glutaminásica equivalentes a EcA II selvagem. Nossos resultados mostram promissoras possibilidades de EcA II mutantes com maior estabilidade frente às proteases sanguíneas humanas e possivelmente menos imunogênicas. / Escherichia coli L-asparaginase (EcA II) is an enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL), acting in the depletion of the amino acid L-asparagine, which is essential for cancer cells proliferation. However, treatment with L-asparaginase is associated with a high rate of hypersensitivity, due to formation of anti-L-asparaginase antibody and the enzyme cleavage by the serum proteases asparagine endopeptidase (AEP) and cathepsin B (CTSB). Furthermore, the neurotoxicity is associated with the effect of the enzyme L-glutaminase activity. The main aim of the current work is to obtain variants of EcA II (gene ansB) with an equivalent catalytic efficiency, greater resistance to proteolytic cleavage and a reduced glutaminase activity. For such purpose, through error-prone polymerase chain reaction (epPCR) of gene ansB, a library of 1128 clones was constructed in pET15b vector and expressed in BL21(DE3). None mutant with an asparaginase activity equivalent to EcA II wild type showed a reduced glutaminase activity. Among the screened clones, one mutant (T161I) was resistant to CTSB proteolytic cleavage and two mutants (Q190L e P40S/S206C) were resistant to both CTSB and AEP proteolytic cleavages. These three mutants were EcA II wild type equivalents in asparaginase and glutaminase activities. Our data show promising new possibilities of mutant EcA II presenting higher stability against human serum proteolytic cleavage and maybe lower immunogenicity.
|
58 |
Avaliação da atividade e resistência à clivagem proteolítica de L-asparaginases recombinantes obtidas por reação em cadeia da polimerase propensa a erro / Evaluation of the activity and resistance to proteolytic cleavage of recombinant L-asparaginases obtained by error-Prone polymerase chain reactionMariane Augusta Domingues Rodrigues 30 March 2016 (has links)
A L-Asparaginase II de Escherichia coli (EcA II) é uma enzima amplamente utilizada no tratamento da Leucemia Linfoblástica Aguda (LLA), atuando na depleção do aminoácido L-asparagina, o qual é fundamental para a multiplicação das células cancerosas. Contudo, o tratamento com a EcA II está associado a altos índices de hipersensibilidade, devido à formação de anticorpos anti-L-asparaginase e à clivagem da enzima pelas proteases sanguíneas asparagina endopeptidase (AEP) e catepsina B (CTSB). Também ocorre neurotoxicidade associada ao efeito L-glutaminase da enzima. O principal objetivo do presente trabalho é a obtenção de mutantes da EcA II (gene ansB) com equivalente eficiência catalítica, maior resistência à clivagem proteolítica e menor atividade glutaminase. Para este propósito, através da reação em cadeia da polimerase propensa a erro (epPCR) do gene ansB, foi construída uma biblioteca de 1128 clones expressos no vetor pET15b em BL21(DE3). Nenhum mutante com atividade asparaginásica equivalente à EcA II selvagem apresentou atividade glutaminásica inferior à esta. Dentre os clones triados obtivemos um mutante (T161I) resistente à clivagem proteolítica pela CTSB e dois mutantes (Q190L e P40S/S206C) resistentes à clivagem proteolítica por ambas AEP e CTSB. Estes três mutantes apresentaram atividade asparaginásica e glutaminásica equivalentes a EcA II selvagem. Nossos resultados mostram promissoras possibilidades de EcA II mutantes com maior estabilidade frente às proteases sanguíneas humanas e possivelmente menos imunogênicas. / Escherichia coli L-asparaginase (EcA II) is an enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL), acting in the depletion of the amino acid L-asparagine, which is essential for cancer cells proliferation. However, treatment with L-asparaginase is associated with a high rate of hypersensitivity, due to formation of anti-L-asparaginase antibody and the enzyme cleavage by the serum proteases asparagine endopeptidase (AEP) and cathepsin B (CTSB). Furthermore, the neurotoxicity is associated with the effect of the enzyme L-glutaminase activity. The main aim of the current work is to obtain variants of EcA II (gene ansB) with an equivalent catalytic efficiency, greater resistance to proteolytic cleavage and a reduced glutaminase activity. For such purpose, through error-prone polymerase chain reaction (epPCR) of gene ansB, a library of 1128 clones was constructed in pET15b vector and expressed in BL21(DE3). None mutant with an asparaginase activity equivalent to EcA II wild type showed a reduced glutaminase activity. Among the screened clones, one mutant (T161I) was resistant to CTSB proteolytic cleavage and two mutants (Q190L e P40S/S206C) were resistant to both CTSB and AEP proteolytic cleavages. These three mutants were EcA II wild type equivalents in asparaginase and glutaminase activities. Our data show promising new possibilities of mutant EcA II presenting higher stability against human serum proteolytic cleavage and maybe lower immunogenicity.
|
Page generated in 0.0353 seconds